Therapy Areas: Respiratory
19 October 2021 - - US-based biopharmaceutical company AnHeart Therapeutics has launched sponsored research to evaluate AB-329, an AXL inhibitor in metastatic breast cancer, the company said.
19 October 2021 - - The US Food and Drug Administration approved the first interchangeable biosimilar product to treat certain inflammatory diseases, the agency said.

Cyltezo (a...
18 October 2021 - Biopharmaceutical company Medigen Vaccine Biologics Corporation on Friday published data from its MVC-COV1901 vaccine phase 2 clinical trial demonstrating promising immunogenicity an...
15 October 2021 - - US-based clinical-stage company Tizona Therapeutics, Inc's lead investigational therapy, TTX-080, a novel antibody targeting HLA-G, has advanced to Phase 1b, the company said....
15 October 2021 - - US-based Exelixis, Inc. (NASDAQ: EXEL) has exercised its exclusive option under its July 2019 agreement with Aurigene Discovery Technologies Ltd. to in-license XL114 (formerly...
15 October 2021 - Biopharmaceutical company Medigen Vaccine Biologics Corporation on Friday published data from its MVC-COV1901 vaccine phase 2 clinical trial demonstrating promising immunogenicity an...
Related Headlines